» Articles » PMID: 25938342

Protein Tyrosine Kinase 6 Regulates UVB-Induced Signaling and Tumorigenesis in Mouse Skin

Overview
Publisher Elsevier
Specialty Dermatology
Date 2015 May 5
PMID 25938342
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Protein tyrosine kinase 6 (PTK6, also called BRK) is an intracellular tyrosine kinase expressed in the epithelial linings of the gastrointestinal tract and the skin, where it is expressed in nondividing differentiated cells. We found that PTK6 expression increases in the epidermis following UVB treatment. To evaluate the roles of PTK6 in the skin following UVB-induced damage, we exposed back skin of Ptk6 +/+ and Ptk6 -/- SENCAR mice to incremental doses of UVB for 30 weeks. Wild-type mice were more sensitive to UVB and exhibited increased inflammation and greater activation of signal transducer and activator of transcription-3 (STAT3) than Ptk6-/- mice. Disruption of Ptk6 did not have an impact on proliferation, although PTK6 was expressed and activated in basal epithelial cells in wild-type mice following UVB treatment. However, wild-type mice exhibited shortened tumor latency and increased tumor load compared with Ptk6-/- mice, and STAT3 activation was increased in these tumors. PTK6 activation was detected in UVB-induced tumors, and this correlated with increased activating phosphorylation of focal adhesion kinase (FAK) and breast cancer anti-estrogen resistance 1 (BCAR1). Activation of PTK6 was also detected in human squamous cell carcinomas of the skin. Although PTK6 has roles in normal differentiation, it also contributes to UVB-induced injury and tumorigenesis in vivo.

Citing Articles

Impaired activation of succinate-induced type 2 immunity and secretory cell production in the small intestines of Ptk6-/- male mice.

Vlajic K, Bie W, Gilic M, Tyner A Cell Death Dis. 2024; 15(10):777.

PMID: 39461944 PMC: 11513114. DOI: 10.1038/s41419-024-07149-9.


Construction of a Secondary Enclosure for UVB Irradiation of Mice.

Choi J, Bordeaux Z, Braun G, Davis C, Parthasarathy V, Deng J JID Innov. 2023; 3(1):100107.

PMID: 36704704 PMC: 9872852. DOI: 10.1016/j.xjidi.2022.100164.


PTK6 inhibits autophagy to promote uveal melanoma tumorigenesis by binding to SOCS3 and regulating mTOR phosphorylation.

Liu B, Yao X, Zhang C, Liu Y, Wei L, Huang Q Cell Death Dis. 2023; 14(1):55.

PMID: 36690663 PMC: 9870980. DOI: 10.1038/s41419-023-05590-w.


Genomic Designs of rAAVs Contribute to Pathological Changes in the Livers and Spleens of Mice.

Mulcrone P, Zhang J, Pride P, Lam A, Frabutt D, Ball-Kell S Adv Cell Gene Ther. 2022; 2022.

PMID: 36507314 PMC: 9730939. DOI: 10.1155/2022/6807904.


Targeting protein tyrosine kinase 6 in cancer.

Gilic M, Tyner A Biochim Biophys Acta Rev Cancer. 2020; 1874(2):188432.

PMID: 32956764 PMC: 7716696. DOI: 10.1016/j.bbcan.2020.188432.


References
1.
Serfas M, Tyner A . Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases. Oncol Res. 2003; 13(6-10):409-19. DOI: 10.3727/096504003108748438. View

2.
Kim D, Chan K, Sano S, DiGiovanni J . Signal transducer and activator of transcription 3 (Stat3) in epithelial carcinogenesis. Mol Carcinog. 2007; 46(8):725-31. DOI: 10.1002/mc.20342. View

3.
Peng M, Emmadi R, Wang Z, Wiley E, Gann P, Khan S . PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors. Oncotarget. 2014; 5(15):6038-48. PMC: 4171611. DOI: 10.18632/oncotarget.2153. View

4.
Gierut J, Zheng Y, Bie W, Carroll R, Ball-Kell S, Haegebarth A . Disruption of the mouse protein tyrosine kinase 6 gene prevents STAT3 activation and confers resistance to azoxymethane. Gastroenterology. 2011; 141(4):1371-80, 1380.e1-2. PMC: 3448944. DOI: 10.1053/j.gastro.2011.06.071. View

5.
Haegebarth A, Perekatt A, Bie W, Gierut J, Tyner A . Induction of protein tyrosine kinase 6 in mouse intestinal crypt epithelial cells promotes DNA damage-induced apoptosis. Gastroenterology. 2009; 137(3):945-54. PMC: 2767275. DOI: 10.1053/j.gastro.2009.05.054. View